We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
42 result(s) found, displaying 31 to 40
-
Prescription medicine registrationActive ingredients: eslicarbazepine acetate.
-
Cancellation by sponsorRequested by Maxx Pharma Pty Ltd
-
Cancellation by sponsorRequested by Maxx Pharma Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OGIVRI trastuzumab (rch) 150 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Opicapone
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FULPHILA pegfilgrastim 6 mg/0.6 mL pre-filled syringe.
-
Prescription medicine decision summaryTGA decision: Ongentys (opicapone) is approved as adjunctive therapy in adult patients with Parkinson's disease.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEMGLEE insulin glargine (rDNA) 100 IU/mL, 3 mL solution for injection injector pen.